| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 46.61B | 43.40B | 30.17B | 20.45B | 13.66B | 5.72B |
| Gross Profit | 23.39B | 21.80B | 13.99B | 9.40B | 5.27B | 2.78B |
| EBITDA | 8.74B | 8.41B | 6.01B | 3.53B | 1.95B | 1.72B |
| Net Income | 5.63B | 5.56B | 4.14B | 2.51B | 1.24B | 1.22B |
Balance Sheet | ||||||
| Total Assets | 31.39B | 33.06B | 22.71B | 15.89B | 8.24B | 3.52B |
| Cash, Cash Equivalents and Short-Term Investments | 11.75B | 11.50B | 8.67B | 7.79B | 4.64B | 1.90B |
| Total Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Liabilities | 13.75B | 16.11B | 11.57B | 8.88B | 4.78B | 1.30B |
| Stockholders Equity | 17.64B | 16.95B | 11.14B | 7.00B | 3.46B | 2.21B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 4.66B | 1.07B | 2.50B | 3.05B | 1.19B |
| Operating Cash Flow | 0.00 | 5.29B | 4.76B | 4.87B | 3.54B | 1.42B |
| Investing Cash Flow | 0.00 | -2.70B | -3.89B | -2.76B | -793.94M | -402.59M |
| Financing Cash Flow | 0.00 | 244.00M | 0.00 | 1.04B | 0.00 | 526.88M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | ¥63.00B | 14.61 | ― | 3.34% | 11.81% | 18.17% | |
73 Outperform | ¥114.56B | 19.91 | ― | ― | 37.31% | 13.66% | |
72 Outperform | ¥116.85B | 16.19 | 17.33% | 4.06% | -8.93% | 48.98% | |
66 Neutral | ¥54.95B | 9.40 | ― | 3.07% | 1.56% | 1.72% | |
63 Neutral | ¥48.58B | 24.40 | ― | 2.06% | 15.45% | -9.67% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
54 Neutral | ¥40.45B | 83.80 | ― | ― | 22.37% | 655.34% |